✦ LIBER ✦

Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial

✍ Scribed by Martee L. Hensley; John A. Blessing; Robert Mannel; Peter G. Rose

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fixed-dose rate gemcitabine plus docetax

✍ Martee L. Hensley; John A. Blessing; Koen DeGeest; Ovadia Abulafia; Peter G. Ros 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 185 KB

A randomized phase III trial of gemcitab

✍ Hensley, M.L.; Miller, A.; O'Malley, D.M.; Mannel, R.S.; Behbakht, K.; Bakkum-Ga 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Phase II trial of gemcitabine as second-

✍ Katherine Y Look; Alan Sandler; John A Blessing; Joseph A Lucci III; Peter G Ros 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Bevacizumab plus gemcitabine and oxalipl

✍ David Fogelman; Mehrdad Jafari; Gauri R. Varadhachary; Henry Xiong; Susie Bulloc 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB

Re: Phase II Trial of Cisplatin, Gemcita

✍ Wood, David P. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 105 KB

Docetaxel/Gemcitabine Administered Every

✍ Amadeu Pelegrí; Lourdes Calvo; Antonio Antón; José I. Mayordomo; Jesús Florián; 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 107 KB